A stochastic model for prostate-specific antigen levels

Mathematical Biosciences

Volumn 190, Issue 2, 2004, Pages 113-126

  Dayananda, P W A ^a   Kemper, John T ^a   Shvartsman, Mikhail M ^a  

^a UNIVERSITY OF ST THOMAS   (United States)

Author keywords

35K57; 60G51; 60H30; 60H35; 92B15; Chapman Kolmogorov partial differential equation; Continuous stochastic model; Deterministic model; Exponential decay; Method of images; Prostate cancer; Prostate specific antigen (PSA); Stochastic differential equation

Indexed keywords

BOUNDARY CONDITIONS; PARAMETER ESTIMATION; PARTIAL DIFFERENTIAL EQUATIONS; RADIOTHERAPY;

PROSTATE-SPECIFIC ANTIGEN (PSA); TIME-DEPENDENT DENSITY;

ANTIGENS;

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; MATHEMATICAL COMPUTING; PROSTATE CANCER; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; STOCHASTIC MODEL;

DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; STOCHASTIC PROCESSES; TIME FACTORS;

EID: 3242710586     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2004.04.001     Document Type: Article

References (19)

1. Swanson K.R., True L.D., Lin D.W., Buhler K.R., Vessella R.L., Murray J.D. A quantitative model for the dynamics of serum prostate-specific antigen as a marker for cancerous growth. Am. J. Pathol. 158:2001;2195
2. Ellis W.J., Vessella R.L., Buhler K.R., Baldou F., True L.D., Bigler S.A., Curtis D., Lange P.H. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin. Cancer Res. 2:1996;1039
3. Wheldon T.E. Mathematical Models in Cancer Research. 1998;IOP, Glasgow
4. Kaplan I., Prestige B.R., Cox R.S., Bagshaw M.A. Prostate-specific antigen after irradiation for prostate carcinoma. J. Urol. 144:1990;1172
5. Kaplan I., Cox R.S., Bagshaw M.A. Prostate-specific antigen after external beam irradiation: follow-up. J. Urol. 149:1993;519
6. Killian C.S., Yang N., Emrich L.J., Vargas F.P., Kuriyama M., Wang M.C., Slack N.H., Papsidero L.D., Murphy G.P., Chu T.M. The investigators of the National Prostate Cancer Project. Prognostic importance of prostate-specific antigen for monitoring patients with stage and prostate cancer. Cancer Res. 45:1995;886
7. Landmann C., Hunig R. Prostate-specific antigen as an indicator of response to radiotherapy in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 17:1989;1073
8. Ritter M.A., Messing E.M., Shanahan T.G., Potts S., Chappell R.J., Kinsella T.J. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J. Clin. Oncol. 10:1992;1208
9. Russell K.J., Dunatov C., Hafferman M.D., Griffeth J.T., Polissar G.L., Pelton J., Cole S.B., Taylor E.W., Weins L.W., Koh W.J., Austin, Seymour M.M., Griffin B.R., Russel A.H., Laramore G.E., Griffin T.W. Prostate-specific antigen in the management of patients treated with primary radiation therapy. J. Urol. 146:1991;1046
10. Zagars G.K., Sherman N.E., Babaian R.J. Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer. 67:1991;412
11. Dayananda P.W.A., Taylor J.M.G., Whiting D.G. Prostate cancer: progression of prostate-specific antigen after external beam irradiation. Math. Biosci. 182:2003;127
12. Cox R.S., Kaplan I.D., Bagshaw M.A. Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 28:1993;23
13. Kaplan I.D., Cox R.S., Bagshaw M.A. A model of prostatic carcinoma tumor kinetics based on prostate-specific antigen levels after radiation therapy. Cancer. 68:1991;400
14. Iosifescu M., Tautu P. Stochastic Processes and Applications in Biology and Medicine. Part I. Theory. 1973;Springer
15. Cox D.R., Miller H.D. The Theory of Stochastic Processes. 1984;Chapman and Hall, New York
16. Taylor J.M.G., Griffith K., Sandler H.M. Definitions of biochemical failure in prostate cancer following radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 50:2001;1212
17. M. Yu, N.J. Law, J.M.G. Taylor, H.M. Sandler, Joint longitudinal- survival-cure models and their application to prostate cancer, Stat. Sin., in press
18. Sandler H.M., Dunn R.L., McLaughlin P.W., Hayman J.A., Sullivan M.A., Taylor J.M.G. Overall survival after PSA-detected recurrence following conformal radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 48:2000;629
19. Law N.J., Taylor J.M.G., Sandler H.M. The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics. 3:2002;547